CTRP6 inhibits cell proliferation and ECM expression in rat mesangial cells cultured under TGF-β1 - 31/12/17
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 5 |
| Vidéos | 0 |
| Autres | 0 |
Graphical abstract |
Abstract |
C1q/tumor necrosis factor-related protein 6 (CTRP6), a member of CTRPs family, was involved in fibrosis. However, the biological function of CTRP6 in renal fibrosis remains elusive. This study aimed to examine the role of CTRP6 in renal fibrosis and explore the possible mechanism. Our results demonstrated that the expression of CTRP6 was significantly downregulated in renal fibrotic tissues and TGF-β1-treated NRK-49F cells. In addition, overexpression of CTRP6 inhibited the proliferation, migration, and ECM expression in TGF-β1-treated NRK-49F cells. Furthermore, overexpression of CTRP6 attenuated TGF-β-induced phosphorylation of ERK1/2 in NRK-49F cells. The ERK1/2 inhibitor U0126 enhanced the inhibitory effects of CTRP6 overexpression on cell proliferation, migration and ECM expression in TGF-β1-stimulated NRK-49F cells. In conclusion, we have demonstrated that CTRP6 suppressed ECM expression in renal fibroblasts induced by TGF-β1 through the ERK signaling pathway. Therefore, CTRP6 may be a potential therapeutic target for the treatment of renal fibrosis.
Le texte complet de cet article est disponible en PDF.Keywords : C1q/tumor necrosis factor-related protein 6 (CTRP6), Renal fibrosis, TGF-β1, Extracellular matrix (ECM)
Plan
Vol 97
P. 280-285 - janvier 2018 Retour au numéro
Article précédent
- Role of endogenous hydrogen sulfide in cardiac mitochondrial preservation during ischemia reperfusion injury
- Sanhitha Nandi, Sriram Ravindran, Gino A. Kurian
- Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer
- Farhad Jeddi, Narges Soozangar, Mohammad Reza Sadeghi, Mohammad Hossein Somi, Masoud Shirmohamadi, Amir-Taher Eftekhar-Sadat, Nasser Samadi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?